SCHEMBL21468505

SCHEMBL21468505

COc1cc2c(cc1NC(=O)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)CCCCC2

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 5/20 0.75
▸ MAPT P10636 6/20 0.73
▸ SMN1; SMN2 Q16637 4/20 0.73
▸ LMNA P02545 3/20 0.73
▸ ALDH1A1 P00352 3/20 0.73
▸ HTT P42858 2/20 0.73
▸ HPGD P15428 1/20 0.73
▸ KDM4E B2RXH2 4/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ RAB9A P51151 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ ALOX15 P16050 1/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.47
▸ TP53 P04637 1/20 0.45
▸ GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21468448 0.90 DHODH (0.80) DHODHMAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL21468515 0.90 DHODH (0.80) DHODHMAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL21468478 0.87 DHODH (0.84) DHODHMAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL21499393 0.87 MAPT (0.58) DHODHMAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL21468457 0.86 DHODH (1.00) DHODHMAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL21468502 0.84 DHODH (0.76) DHODHMAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL21468450 0.84 DHODH (0.71) DHODHMAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL21499320 0.83 DHODH (0.77) DHODHMAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL21468525 0.82 DHODH (0.76) DHODHMAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL21468511 0.82 DHODH (0.75) DHODHMAPTSMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450263-B2 Benzo annulenes as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2019-10-22 — — US disclosed
US-10450263-B2 Benzo annulenes as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2019-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450263-B2 Benzo annulenes as antiviral agents MAVS, ZC3HAV1, GABBR1 DHODH 593/4885MAPT 760/4885SMN1; SMN2 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback